Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Framing and Management of Migraines in Women: An Expert Opinion on Challenges, Current Approaches, and Future Multidisciplinary Perspectives.
Healthcare (Basel)
January 2025
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Migraines are a common neurological disorder that significantly impact women, especially during their reproductive years. Hormonal, neurological, and lifestyle factors shape migraine patterns, with fluctuations during menstruation, pregnancy, perimenopause, and menopause influencing migraine prevalence and severity. This expert opinion explores current challenges, therapeutic strategies, and future directions for personalized care, addressing the limited inclusion of women in clinical research across different life stages.
View Article and Find Full Text PDFFactors associated with menstrual-related disturbances following SARS-CoV-2 vaccination: a Spanish retrospective observational study in formerly menstruating women.
Women Health
January 2025
Neuroimmunophysiology and Chrononutrition Research Group, Department of Physiology, Universidad de Extremadura, Badajoz, Spain.
Background: A growing body of evidence suggests a potential link between the SARS-CoV-2 vaccine and menstrual changes in women who were menstruating at the time of vaccination. Nevertheless, the prevalence of this event in those with secondary amenorrhea for different causes, i.e.
View Article and Find Full Text PDFThe role of short luteal phases on cycle regularity during the perimenopausal transition.
Menopause
December 2024
From the University of Aarhus, Institute for Clinical Medicine, Aarhus, Denmark.
Objective: The aim of the study was to explore the correlation between short luteal phases and cycle irregularity in perimenopausal women.
Methods: In this feasibility pilot study, daily salivary-progesterone measurements from presumed perimenopausal women have been analyzed using the inne minilab-an at-home system for ovulation and cycle tracking. Data were collected between 2020 to August 2022 from 29 women from Germany and Austria from users over the age of 42 years.
Perimenopausal combined hormonal contraception: focus on sexual function.
Climacteric
November 2024
Obstetrics and Gynecology Department, Marmara University School of Medicine, Istanbul, Turkey.
Age alone should not be an absolute contraindication for any contraceptive methods. However, medical eligibility criteria for combined hormonal contraception (CHC) use must be taken into consideration when choosing an appropriate contraceptive method. Women should be counseled on the benefits and risks of CHC while in their 40s.
View Article and Find Full Text PDFTales from the clinic: Contraception and perimenopause.
Post Reprod Health
December 2024
Department of Gynaecology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Effective contraception consultations are essential to delivering high-quality perimenopause care and reducing unplanned pregnancies. Contraception can be used independently, or in conjunction with hormone replacement therapy (HRT). Newer contraception options provide enhanced opportunities to individualise perimenopause care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!